Differences in NSAID Tolerability Profiles Kenneth J. SkeithMatthew WrightPaul Davis Leading Article 27 October 2012 Pages: 183 - 195
A Risk-Benefit Assessment of Conventional versus Intensive Insulin Therapy Per Reichard Commentary 27 October 2012 Pages: 196 - 202
A Risk-Benefit Assessment of Celiprolol in the Treatment of Cardiovascular Disease Martin J. KendallIris Rajman Review Article 27 October 2012 Pages: 220 - 232
Novel Oral Drug Formulations Alexander T. FlorencePraful U. Jani Review Article 27 October 2012 Pages: 233 - 266
Adverse Interaction between Warfarin and Indomethacin Thomas Y. K. ChanSiu F. LuiJulian A. J. H. Critchley Case Report 27 October 2012 Pages: 267 - 269
Erratum to Drug-Induced Hepatic Disorders Døssing MartinSonne Jesper Erratum 27 October 2012 Pages: 269 - 269